Our DNA damage recovery assay showed that pretreating MLL-rearranged leukemia cells with SYC-522 significantly reduced the proportion of viable γH2AX+ cells, and increased the apoptotic (cPARP+) cells after mitoxantrone treatment. The gene discussed is KMT2A; the disease is leukemia.